Answer
Lazertinib may harm the foetus based on its mechanism of action and animal studies showing reduced embryo-foetal survival and foetal body weight; there are no data from pregnant women.
Sources for this answer
- Lazcluze 80 mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked